You just read:

XBiotech Receives Fast Track Designation from FDA for True Human™ Monoclonal Antibody Therapy Targeting Inflammatory Cytokine IL-1a for Restenosis

News provided by

XBiotech

Jan 03, 2013, 03:00 ET